Regulatory Scrutiny Intensifies for Hims & Hers Following Super Bowl Ad
The telehealth provider Hims & Hers finds itself navigating turbulent regulatory waters. Its recent expansion into the multi-billion dollar testosterone ...
The telehealth provider Hims & Hers finds itself navigating turbulent regulatory waters. Its recent expansion into the multi-billion dollar testosterone ...
Telehealth provider Hims & Hers Health is making a bold strategic move to capture a significant share of the lucrative ...
Telehealth innovator Hims & Hers Health is pursuing a significant expansion opportunity that could unlock substantial new revenue streams. Rather ...
While telemedicine provider Hims & Hers Health continues to demonstrate impressive user acquisition and revenue expansion, recent actions by its ...
The telehealth provider Hims & Hers appears to be staging a significant recovery after months of facing skepticism from market ...
A landmark court decision has removed the most significant legal threat facing the rapidly expanding market for affordable weight-loss medications. ...
The fundamental legality of its business model has emerged as an existential threat to telehealth provider Hims & Hers. An ...
Telehealth provider Hims & Hers Health, Inc. faces a critical juncture as the August 25, 2025, deadline passes for shareholders ...
Telehealth provider Hims & Hers Health, Inc. finds itself confronting significant legal challenges and a pressing deadline for shareholders. The ...
Shares of telehealth provider Hims & Hers Health are under significant pressure following a dual blow of legal challenges and ...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com